PRMT5 and neoplasm: Importantly, and in agreement with our limiting dilution analysis using bulk cell population (Figures 2B and 2G), depletion of PRMT5 affected the tumor-initiating capacity of only ESA+CD24lowCD44+ BCSCs (Figure S3E), not the differentiated population (Figure S3G).